Biomed. Papers 145(2), 75-76 (2001) | DOI: 10.5507/bp.2001.016

OSTEOPROTEGERIN AND BONE DENSITY

David Stejskala, Martin Zurekb, Josef Bartekc, Libor Jedelskýa, Viktor Růžičkaa
a Department of Laboratory Medicine, Hospital Šternberk, Czech Republic, Jívavská 20, 785 16
b Department of Internal Medicine, Hospital Šternberk, Czech Republic, Jívavská 20, 785 16
c Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacký University, Olomouc

Aim of study was determine if a correlation exists between bone mass density and concentration of osteoprotegerin.We examined the group of 199 patients of mean age of 63 years. Of the group under study, 31 patients hadnormal bone density (T score >–1 and

Keywords: Osteoprotegerin, Bone density, Osteoporosis

Received: January 10, 2002; Published: December 1, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal, D., Zurek, M., Bartek, J., Jedelský, L., & Růžička, V. (2001). OSTEOPROTEGERIN AND BONE DENSITY. Biomedical papers, 145(2), 75-76. doi: 10.5507/bp.2001.016
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Shalhoub, V., Faust, J., Boyle, W. J. et al. (1999) Osteoprotegerin and osteoprotegerin ligand effects on osteoclasts formation from human peripheral blood mononuclear cell precursors. J. Cell. Biochem. 72, 251-261. Go to original source... Go to PubMed...
    2. Browner, W. B., Li-Yang, L., Cummingsa, S. R. (2001) Associations of Serum Osteoprotegerin Levels With Diabetes, Stroke, Bone density, fractures and mortality in Elderly Women. The J of Clin. Endocrinology and Metabolism 86, 631-637. Go to original source...
    3. Yano, K., Shibata, O., Mizuno, A., Kobayashi, F., Higashio, K., Morinaga, T., Tsuda, E. et al. (2001) Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (opg/ocif): possible role of opg/ocif in the prevention of osteoporosis in pregnancy. Biochem. Biophys. Res. Commun. 288, 217-224. Go to original source... Go to PubMed...

    Return to the content